CCO Independent Conference Highlights of the IASLC 2022 World Conference on Lung Cancer *

August 6-9, 2022; Vienna, Austria
Download capsule summaries highlighting key studies from IASLC 2022 WCLC and then read expert insights on these studies in our Expert Analysis text module.

Share

Program Content

11 Capsule Summary Slidesets

Activities

TROPION-Lung02: Dato-DXd + Pembro and CT
TROPION-Lung02: Initial Results From Phase I Study of Datopotamab Deruxtecan + Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2022

Expires: August 17, 2023

Treatment Inequities in NSCLC
Population-Based Assessment of Socioeconomic Treatment Inequities With Biomarker-Guided Targeted Therapy and Immunotherapy for Patients With NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2022

Expires: August 16, 2023

CodeBreaK101: Sotorasib + RMC-4630
CodeBreaK101: Phase Ib/II Study With Sotorasib + RMC-4630, an SHP2 Inhibitor, in Advanced NSCLC and Other Solid Tumors With KRAS p.G12C Mutation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 12, 2022

Expires: August 11, 2023

CodeBreaK100/101: Sotorasib + Atezo or Pembro
CodeBreaK100/101: Phase Ib Report of Safety and Efficacy of Sotorasib + Atezolizumab or Pembrolizumab in Patients With Pretreated KRAS G12C–Mutated NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2022

Expires: August 15, 2023

DeLLphi-300: Tarlatamab in SCLC
DeLLphi-300: Updated Data From Phase I Study of Tarlatamab, a DLL3-Targeted T-Cell Engager, in Relapsed/Refractory SCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 12, 2022

Expires: August 11, 2023

HUDSON Umbrella Study
HUDSON: Open-Label, Multidrug Umbrella Phase II Study in Patients With Advanced NSCLC After Progression on PD-1/PD-L1 Inhibitor Therapy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2022

Expires: August 17, 2023

Second-Course Pembrolizumab in NSCLC
Results of a Pooled Outcomes Analysis of Phase III Trials Using a Second Course of Pembrolizumab in Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2022

Expires: August 15, 2023

YESS: Personalized Smoking Cessation Support
YESS: Effectiveness of Adding Colocated Personalized Smoking Cessation Support to a Lung Cancer Screening Program
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2022

Expires: August 17, 2023

CALGB 140503: Sub-Lobar Resection
CALGB 140503 (Alliance): Phase III Trial of Lobar or Sublobar Resection for Peripheral Clinical Stage IA NSCLC With Tumor Size ≤2 cm
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2022

Expires: August 18, 2023

IMpower010: OS With Adjuvant Atezo in Early-Stage NSCLC
IMpower010: Updated Data of Phase III Trial of Adjuvant Atezolizumab vs BSC in Resected Stage IB-IIIA NSCLC After Adjuvant Chemotherapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2022

Expires: August 15, 2023

NADIM II: Neoadjuvant Nivo + CT
NADIM II: Survival Results From Phase II Study of Nivolumab + Chemotherapy vs Chemotherapy as Neoadjuvant Treatment for Resectable IIIA-B NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2022

Expires: August 17, 2023

Activities

WCLC 2022: Key Studies
An Expert’s Guide to WCLC 2022: A Preview of the Top Abstracts
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

2022 WCLC Highlights
Independent Conference Coverage of the IASLC 2022 World Conference on Lung Cancer
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 25, 2022

Expires: October 24, 2023

Faculty

cover img faculity

Wade T. Iams, MD, MSCI

Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Heather Wakelee, MD

Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Stanford University/Stanford Cancer Institute
Stanford, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Turning Point Therapeutics Inc

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.